Percutaneous Transluminal Coronary Angioplasty Clinical Trial
Official title:
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
The purpose of this study is to determine whether ABSORB bioresorbable vascular scaffold is non-inferior to XIENCE everolimus-eluting cobalt-chromium stent with respect to target-lesion failure (TLF) at 1 year.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00767663 -
Persantin Preceding Elective PCI
|
Phase 4 | |
Withdrawn |
NCT02784418 -
The SHINE-CTO Trial
|
N/A | |
Active, not recruiting |
NCT02042300 -
XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
|
||
Recruiting |
NCT03209414 -
Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
|
||
Active, not recruiting |
NCT02939872 -
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events
|
Phase 4 | |
Recruiting |
NCT05972070 -
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
|
||
Recruiting |
NCT02797561 -
Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions
|
||
Not yet recruiting |
NCT04455568 -
Establish a Telecare Model of Acute Coronary Syndrome Patient With Heart Stent Implantation by a Non-invasive Wearable Device and Artificial Intelligence Cloud to Reducing Medical Adverse Events.
|
||
Recruiting |
NCT01186133 -
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
|
||
Recruiting |
NCT02497014 -
The European Bifurcation Club Left Main Study
|
N/A | |
Terminated |
NCT02831218 -
Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation
|
N/A |